SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH
K-Number: K910155 · 1991-02-07
Advertisement
Device Summary
Frequently Asked Questions
What is the SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH?
SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH is a medical device that received FDA 510(k) clearance on 1991-02-07. The listed applicant is Scimed Life Systems, Inc.. The 510(k) number is K910155.
When did SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH receive FDA 510(k) clearance?
SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH received FDA 510(k) clearance on 1991-02-07, under 510(k) number K910155.
Who is the listed applicant for SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH?
The FDA 510(k) record lists Scimed Life Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH?
The FDA product code for SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH is LIT.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Scimed Life Systems, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LIT)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement